Global Cancer Treatment Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • ID:PD015227
  • February 2021
  • GIR (Global Info Research)
                          

The Global Cancer Treatment Drugs Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.

The Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cancer Treatment Drugs size is estimated to be xx million in 2020 from USD 155240 million in 2019, with a change of XX% between 2019 and 2020. The global Cancer Treatment Drugs market size is expected to grow at a CAGR of 8.4% for the next five years.

Market segmentation
Cancer Treatment Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

  •     Chemotherapy
  •     Targeted Therapy
  •     Immunotherapy
  •     Hormonal Therapy (Biologic Therapy)
  •     Others

Market segment by Application can be divided into
  •     Blood Cancer
  •     Breast Cancer
  •     Gastrointestinal Cancer
  •     Prostate Cancer
  •     Respiratory/Lung Cancer
  •     Others

The key market players for global Cancer Treatment Drugs market are listed below:
  •     Roche
  •     Novartis
  •     Celgene
  •     Bristol-Myers Squibb
  •     Amgen
  •     Johnson & Johnson
  •     Pfizer
  •     Takeda
  •     Eli Lilly
  •     AstraZeneca
  •     Astellas
  •     Merck & Co.
  •     Sanofi
  •     Bayer
  •     Biogen Idec
  •     Eisai
  •     Teva
  •     Otsuka
  •     Merck KGaA
  •     Ipsen
  •     AbbVie
  •     Gilead Sciences

Market segment by Region, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  •     Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  •     South America (Brazil, Argentina, Colombia, and Rest of South America)
  •     Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

There are 14 Chapters to deeply display the Global Cancer Treatment Drugs Market.
1 Market Overview
2 Manufacturers Profiles
3 Cancer Treatment Drugs Sales by Manufacturer
4 Market Analysis by Region
5 Market Segment by Type
6 Market Segment by Application
7 North America by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
9 Asia-Pacific by Country, by Type, and by Application
10 South America by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
12 Sales Channel, Distributors, Traders and Dealers
13 Research Findings and Conclusion
14 Appendix

Table of Contents

1 Market Overview
    1.1 Cancer Treatment Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Cancer Treatment Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy
        1.2.5 Hormonal Therapy (Biologic Therapy)
        1.2.6 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Cancer Treatment Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Others
    1.4 Global Cancer Treatment Drugs Market Size & Forecast
        1.4.1 Global Cancer Treatment Drugs Sales in Value (2016-2026))
        1.4.2 Global Cancer Treatment Drugs Sales in Volume (2016-2026)
        1.4.3 Global Cancer Treatment Drugs Price by Type (2016-2026) & (USD/Pcs)
    1.5 Global Cancer Treatment Drugs Production Capacity Analysis
        1.5.1 Global Cancer Treatment Drugs Total Production Capacity (2016-2026)
        1.5.2 Global Cancer Treatment Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Cancer Treatment Drugs Market Drivers
        1.6.2 Cancer Treatment Drugs Market Restraints
        1.6.3 Cancer Treatment Drugs Trends Analysis
2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Cancer Treatment Drugs Product and Services
        2.1.4 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Cancer Treatment Drugs Product and Services
        2.2.4 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.3 Celgene
        2.3.1 Celgene Details
        2.3.2 Celgene Major Business
        2.3.3 Celgene Cancer Treatment Drugs Product and Services
        2.3.4 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.4 Bristol-Myers Squibb
        2.4.1 Bristol-Myers Squibb Details
        2.4.2 Bristol-Myers Squibb Major Business
        2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Product and Services
        2.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.5 Amgen
        2.5.1 Amgen Details
        2.5.2 Amgen Major Business
        2.5.3 Amgen Cancer Treatment Drugs Product and Services
        2.5.4 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.6 Johnson & Johnson
        2.6.1 Johnson & Johnson Details
        2.6.2 Johnson & Johnson Major Business
        2.6.3 Johnson & Johnson Cancer Treatment Drugs Product and Services
        2.6.4 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Cancer Treatment Drugs Product and Services
        2.7.4 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.8 Takeda
        2.8.1 Takeda Details
        2.8.2 Takeda Major Business
        2.8.3 Takeda Cancer Treatment Drugs Product and Services
        2.8.4 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.9 Eli Lilly
        2.9.1 Eli Lilly Details
        2.9.2 Eli Lilly Major Business
        2.9.3 Eli Lilly Cancer Treatment Drugs Product and Services
        2.9.4 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.10 AstraZeneca
        2.10.1 AstraZeneca Details
        2.10.2 AstraZeneca Major Business
        2.10.3 AstraZeneca Cancer Treatment Drugs Product and Services
        2.10.4 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.11 Astellas
        2.11.1 Astellas Details
        2.11.2 Astellas Major Business
        2.11.3 Astellas Cancer Treatment Drugs Product and Services
        2.11.4 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.12 Merck & Co.
        2.12.1 Merck & Co. Details
        2.12.2 Merck & Co. Major Business
        2.12.3 Merck & Co. Cancer Treatment Drugs Product and Services
        2.12.4 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.13 Sanofi
        2.13.1 Sanofi Details
        2.13.2 Sanofi Major Business
        2.13.3 Sanofi Cancer Treatment Drugs Product and Services
        2.13.4 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.14 Bayer
        2.14.1 Bayer Details
        2.14.2 Bayer Major Business
        2.14.3 Bayer Cancer Treatment Drugs Product and Services
        2.14.4 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.15 Biogen Idec
        2.15.1 Biogen Idec Details
        2.15.2 Biogen Idec Major Business
        2.15.3 Biogen Idec Cancer Treatment Drugs Product and Services
        2.15.4 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.16 Eisai
        2.16.1 Eisai Details
        2.16.2 Eisai Major Business
        2.16.3 Eisai Cancer Treatment Drugs Product and Services
        2.16.4 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.17 Teva
        2.17.1 Teva Details
        2.17.2 Teva Major Business
        2.17.3 Teva Cancer Treatment Drugs Product and Services
        2.17.4 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.18 Otsuka
        2.18.1 Otsuka Details
        2.18.2 Otsuka Major Business
        2.18.3 Otsuka Cancer Treatment Drugs Product and Services
        2.18.4 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.19 Merck KGaA
        2.19.1 Merck KGaA Details
        2.19.2 Merck KGaA Major Business
        2.19.3 Merck KGaA Cancer Treatment Drugs Product and Services
        2.19.4 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.20 Ipsen
        2.20.1 Ipsen Details
        2.20.2 Ipsen Major Business
        2.20.3 Ipsen Cancer Treatment Drugs Product and Services
        2.20.4 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.21 AbbVie
        2.21.1 AbbVie Details
        2.21.2 AbbVie Major Business
        2.21.3 AbbVie Cancer Treatment Drugs Product and Services
        2.21.4 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.22 Gilead Sciences
        2.22.1 Gilead Sciences Details
        2.22.2 Gilead Sciences Major Business
        2.22.3 Gilead Sciences Cancer Treatment Drugs Product and Services
        2.22.4 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Cancer Treatment Drugs Sales by Manufacturer
    3.1 Global Cancer Treatment Drugs Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Cancer Treatment Drugs Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Cancer Treatment Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
        3.4.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share
    3.5 Global Cancer Treatment Drugs Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Cancer Treatment Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Cancer Treatment Drugs Market Size by Region
        4.1.1 Global Cancer Treatment Drugs Sales in Volume by Region (2016-2026)
        4.1.2 Global Cancer Treatment Drugs Revenue by Region (2016-2026)
    4.2 North America Cancer Treatment Drugs Revenue (2016-2026)
    4.3 Europe Cancer Treatment Drugs Revenue (2016-2026)
    4.4 Asia-Pacific Cancer Treatment Drugs Revenue (2016-2026)
    4.5 South America Cancer Treatment Drugs Revenue (2016-2026)
    4.6 Middle East and Africa Cancer Treatment Drugs Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Cancer Treatment Drugs Sales in Volume by Type (2016-2026)
    5.2 Global Cancer Treatment Drugs Revenue by Type (2016-2026)
    5.3 Global Cancer Treatment Drugs Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Cancer Treatment Drugs Sales in Volume by Application (2016-2026)
    6.2 Global Cancer Treatment Drugs Revenue by Application (2016-2026)
    6.3 Global Cancer Treatment Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Cancer Treatment Drugs Sales by Type (2016-2026)
    7.2 North America Cancer Treatment Drugs Sales by Application (2016-2026)
    7.3 North America Cancer Treatment Drugs Market Size by Country
        7.3.1 North America Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
        7.3.2 North America Cancer Treatment Drugs Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Cancer Treatment Drugs Sales by Type (2016-2026)
    8.2 Europe Cancer Treatment Drugs Sales by Application (2016-2026)
    8.3 Europe Cancer Treatment Drugs Market Size by Country
        8.3.1 Europe Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
        8.3.2 Europe Cancer Treatment Drugs Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Cancer Treatment Drugs Sales by Type (2016-2026)
    9.2 Asia-Pacific Cancer Treatment Drugs Sales by Application (2016-2026)
    9.3 Asia-Pacific Cancer Treatment Drugs Market Size by Region
        9.3.1 Asia-Pacific Cancer Treatment Drugs Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Cancer Treatment Drugs Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Cancer Treatment Drugs Sales by Type (2016-2026)
    10.2 South America Cancer Treatment Drugs Sales by Application (2016-2026)
    10.3 South America Cancer Treatment Drugs Market Size by Country
        10.3.1 South America Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
        10.3.2 South America Cancer Treatment Drugs Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Cancer Treatment Drugs Sales by Type (2016-2026)
    11.2 Middle East & Africa Cancer Treatment Drugs Sales by Application (2016-2026)
    11.3 Middle East & Africa Cancer Treatment Drugs Market Size by Country
        11.3.1 Middle East & Africa Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Cancer Treatment Drugs Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Cancer Treatment Drugs Typical Distributors
    12.3 Cancer Treatment Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..